Skip to content
    S3

    Section 32

    San Diego, California, United StatesFounded 2017

    Section 32 (now S32) is a venture capital firm that invests in technology companies across all stages, with a particular focus on frontier technology, healthcare, and AI/ML. The firm's strategy involves identifying innovative solutions to complex problems, providing strategic guidance and operational support, and fostering long-term partnerships with its portfolio companies.

    They made 1 investments in the last 12 months. Average disclosed round size is $78.0M (across 44 rounds with reported amounts).

    Find people at Section 32 on Goldilocks AI

    Portfolio

    45

    Fund Size

    $1.8B

    Top Stage

    Series B

    Last 12 Mo

    1

    Team

    Bill Maris

    Bill Maris

    Venture Partner

    Portfolio Breakdown

    Stage Distribution

    Sector Distribution

    Investment Activity

    DealsAvg Round Size

    Portfolio

    45 investments
    CompanyRoundAmountDate
    Endor Labs logoEndor LabsSeries B$93MApr 2025
    EEmaSeed$25MMar 2024
    Endor Labs logoEndor LabsSeries A$70MAug 2023
    Forward Networks logoForward NetworksSeries D$50MJan 2023
    MedCrypt, Inc. logoMedCrypt, Inc.Series B$25MNov 2022
    Stairwell logoStairwellSeries B$45MOct 2022
    Spectral logoSpectralSeries B$23MAug 2022
    Inworld AI logoInworld AISeries A$50MAug 2022
    Parallel Finance logoParallel FinanceGrowth$5MApr 2022
    Cohere logoCohereSeries B$125MFeb 2022
    OONISeries B$75MJan 2022
    Freenome logoFreenomeSeries D$300MDec 2021
    MedArrive logoMedArriveSeries A$25MNov 2021
    Arbor Biotechnologies Inc logoArbor Biotechnologies IncSeries B$215MNov 2021
    Mekonos logoMekonosSeries A$25MNov 2021
    ScienceIO logoScienceIOSeed$8MOct 2021
    Gretel AI logoGretel AISeries B$50MOct 2021
    Wise Systems logoWise SystemsSeries C$50MOct 2021
    TrialSpark logoTrialSparkSeries C$156MSep 2021
    Cohere logoCohereSeries A$40MSep 2021
    FFaro Health Inc.Series A$15MJun 2021
    CC2i GenomicsSeries B$100MApr 2021
    Legacy logoLegacySeries A$10MApr 2021
    MMeatableSeries B$47MMar 2021
    Glympse Bio logoGlympse BioSeries B$46.7MJul 2020
    Page 1 of 2

    Top Co-Investors

    Last updated: 13 March 2026